WS #10148
FDA advisory committee votes 9-0 to approve Moderna's mRNA flu vaccine (mRNA-1010), which showed 27% better efficacy vs standard flu shot.
FDA Panel Backs Moderna mRNA Flu Vaccine
FDA advisory committee votes 9-0 to approve Moderna's mRNA flu vaccine (mRNA-1010), which showed 27% better efficacy vs standard flu shot.